product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
CD19 Antibody (CB19) - BSA Free
catalog :
NBP2-25196
quantity :
0.1 mg (also 0.025 mg)
price :
429 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CB19
reactivity :
human, mouse
application :
western blot, immunocytochemistry, flow cytometry
more info or order :
citations: 20
Reference
Ochiai J, Villanueva L, Niihara H, Niihara Y, Oliva J. Posology and Serum-/Xeno-Free Engineered Adipose Stromal Cells Cell Sheets. Front Cell Dev Biol. 2022;10:873603 pubmed publisher
Wang X, Nakamoto T, Duli x144 ska Molak I, Kawazoe N, Chen G. Regulating the stemness of mesenchymal stem cells by tuning micropattern features. J Mater Chem B. 2016;4:37-45 pubmed publisher
Westrich J, Vermeer D, Silva A, Bonney S, Berger J, Cicchini L, et al. CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8+ T-cell responses by upregulating MHC-I expression. Oncogene. 2019;: pubmed publisher
Fazia T, Pastorino R, Notartomaso S, Busceti C, Imbriglio T, Cannella M, et al. Acid sensing ion channel 2: A new potential player in the pathophysiology of multiple sclerosis. Eur J Neurosci. 2019;49:1233-1243 pubmed publisher
Samanta D, Park Y, Ni X, Li H, Zahnow C, Gabrielson E, et al. Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells. Proc Natl Acad Sci U S A. 2018;115:E1239-E1248 pubmed publisher
Sierra R, Trillo Tinoco J, Mohamed E, Yu L, Achyut B, Arbab A, et al. Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance. Cancer Res. 2017;77:5628-5638 pubmed publisher
Ma S, Deng W, Liu J, Mao L, Yu G, Bu L, et al. Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma. Mol Cancer. 2017;16:99 pubmed publisher
Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L, et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene. 2017;36:4457-4468 pubmed publisher
Li A, Wu Y, Tang F, Li W, Feng X, Yao Z. In Vivo Magnetic Resonance Imaging of CD8+ T Lymphocytes Recruiting to Glioblastoma in Mice. Cancer Biother Radiopharm. 2016;31:317-323 pubmed
Holla S, Prakhar P, Singh V, Karnam A, Mukherjee T, Mahadik K, et al. MUSASHI-Mediated Expression of JMJD3, a H3K27me3 Demethylase, Is Involved in Foamy Macrophage Generation during Mycobacterial Infection. PLoS Pathog. 2016;12:e1005814 pubmed publisher
Fazio F, Zappulla C, Notartomaso S, Busceti C, Bessede A, Scarselli P, et al. Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. Neuropharmacology. 2014;81:237-43 pubmed publisher
Kheradmand T, Wang S, Gibly R, Zhang X, Holland S, Tasch J, et al. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials. 2011;32:4517-24 pubmed publisher
Bankoti J, Burnett A, Navarro S, Miller A, Rase B, Shepherd D. Effects of TCDD on the fate of naive dendritic cells. Toxicol Sci. 2010;115:422-34 pubmed publisher
Deaglio S, Vaisitti T, Billington R, Bergui L, Omede P, Genazzani A, et al. CD38/CD19: a lipid raft-dependent signaling complex in human B cells. Blood. 2007;109:5390-8 pubmed
Deaglio S, Vaisitti T, Bergui L, Bonello L, Horenstein A, Tamagnone L, et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood. 2005;105:3042-50 pubmed
Deaglio S, Capobianco A, Bergui L, Dürig J, Morabito F, Duhrsen U, et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood. 2003;102:2146-55 pubmed
McLellan A, Kapp M, Eggert A, Linden C, Bommhardt U, Brocker E, et al. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood. 2002;99:2084-93 pubmed
Musso T, Deaglio S, Franco L, Calosso L, Badolato R, Garbarino G, et al. CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines. J Leukoc Biol. 2001;69:605-12 pubmed
Deaglio S, Canella D, Baj G, Arnulfo A, Waxman S, Malavasi F. Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As(2)O(3)) on myeloma cells. Leuk Res. 2001;25:227-35 pubmed
Zilber M, Gregory S, Mallone R, Deaglio S, Malavasi F, Charron D, et al. CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation. Proc Natl Acad Sci U S A. 2000;97:2840-5 pubmed
product information
master code :
NBP2-25196
SKU :
NBP2-25196
product name :
CD19 Antibody (CB19) - BSA Free
unit size :
0.1 mg (also 0.025 mg)
description :
The CD19 Antibody (CB19) - BSA Free from Novus is a mouse monoclonal antibody to CD19. This antibody reacts with human,mouse. The CD19 Antibody (CB19) - BSA Free has been validated for the following applications: Flow Cytometry,Western Blot,In vitro assay,Immunocytochemistry/ Immunofluorescence,CyTOF-ready.
target :
CD19
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
CB19
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Intact normal human B cell cells were used as immunogen to generate the CB19 clone.
isotype :
IgG1
purity :
Protein G purified
species :
Human,Mouse
gene symbol :
CD19
accessionNumbers :
P15391
applications :
Flow Cytometry,Western Blot,In vitro assay,Immunocytochemistry/ Immunofluorescence,CyTOF-ready
USD :
429 USD
alt names :
B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.